DrugBiological
Enovin clinical trials
Also written Neublastin.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses enovin is read from its arms, and is right about nine times in ten.
Testing it · 4
- BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar RadiculopathyCompletedPhase 2BiogenNCT01873404Written as BG00010
- Phase 1 Subcutaneous Single and Multiple Ascending Dose Study of BG00010 (Neublastin)CompletedPhase 1BiogenNCT01842126Written as BG00010 IV
- Evaluate the Safety, Tolerability and Pharmacokinetics of BG00010 (Neublastin) Administered to Sciatica ParticipantsCompletedPhase 1BiogenNCT00961766Written as BG00010 (Neublastin)
- Study of the Safety, Tolerability, Pharmacokinetics and Safety of BG00010 (Neublastin) in Subjects With Sciatica.CompletedPhase 1BiogenNCT01405833Written as BG00010 (Neublastin)
Codes
What other systems call enovin · ClinicalTrials.gg INT004204
- MeSH (NLM) C403186enovinOne source NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C403186 | enovin | One source NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.